Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6993 - 7000 of 12091 results

OCR Publishes Checklist and Infographic for Cyber Attack Response
June 14, 2017| Blog| Viewpoint

SCOTUS Ruling Gives a Boost to Biosimilars; FDA Continues to Advance Products Through AdComs
June 14, 2017| Blog| Viewpoint

Amgen v. Sandoz: The Supreme Court’s First Biosimilars Ruling
June 14, 2017| Blog| Viewpoint

PTAB Invalidates Two Cisco Patents Found Valid and Infringed at the ITC
June 14, 2017| Blog| Viewpoint

Upward trend in patent litigation relating to automobiles
June 14, 2017| News

Pumping Up Exceptional Cases Under the Octane Fitness Standard
June 13, 2017| Blog| Viewpoint

U.S. States, Cities, & Corporations Unite to Uphold Paris Climate Accord
June 12, 2017| Blog| Viewpoint

Healthcare Weekly Preview from ML Strategies - Week of June 12, 2017
June 12, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
